Max Robotics — Global Service Robot Directory + US Certification

About

M.A. Orvieto is a pioneering urologic surgeon and researcher whose work has fundamentally shaped the modern approach to robotic-assisted prostate cancer surgery. His primary research focuses on refining surgical techniques and standardizing outcome reporting for radical prostatectomy. Orvieto introduced the revolutionary "octafecta" concept—a comprehensive framework evaluating eight key outcomes including continence, potency, oncologic control, and complication rates—providing a more holistic assessment of surgical success beyond traditional metrics. His early work on the "trifecta" (continence, potency, and cancer control) established benchmarks that have guided surgeons worldwide, with his foundational papers accumulating over 10 citations. Notably, Orvieto developed a modified technique for robotic-assisted simple prostatectomy incorporating vesicourethral anastomosis, improving outcomes for benign prostatic hyperplasia patients. He also advanced salvage robotic-assisted radical prostatectomy for radio-recurrent prostate cancer, describing a reproducible technique with multi-institutional outcomes that offered new hope for patients with recurrent disease. Through these contributions, Orvieto has helped transform robotic prostate surgery from a technical novelty into a precisely measured, outcomes-driven discipline, setting new standards for surgical excellence and patient quality of life.